tm
Seeing Is Believing
tm
Seeing Is Believing
HUMA is currently covered by 6 analysts with an average price target of $8.13. This is a potential upside of $7.14 (1378.18%) from yesterday's end of day stock price of $0.55.
Humacyte's activity chart (see below) currently has 60 price targets and 101 ratings on display. The stock rating distribution of HUMA is 97.06% BUY and 2.94% HOLD.
Analysts average stock forecasts to be materialized ratio is 21.56% with an average time for these price targets to be met of 92 days.
Highest price target for HUMA is $25, Lowest price target is $1.5, average price target is $8.13.
Most recent stock forecast was given by SWAYAMPAKULA RAMAKANTH from HC WAINWRIGHT on 11-Jun-2026. First documented stock forecast 20-Jul-2021.
Currently out of the existing stock ratings of HUMA, 33 are a BUY (97.06%), 1 are a HOLD (2.94%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 14-May-2025
$4
$2.94 (277.36%)
$3
Buy Since 23-Sep-2021
$2
$0.94 (88.68%)
$3
Buy Since 29-Oct-2021
$1.5
$0.44 (41.51%)
$1
Buy Since 09-Sep-2024
$25
$23.94 (2258.49%)
$25
What is HUMA (Humacyte) average time for price targets to be met?
Which analyst has the current highest performing score on HUMA (Humacyte) with a proven track record?
Which analyst has the current lower performing score on HUMA (Humacyte) with a proven track record?
Which analyst has the most public recommendations on HUMA (Humacyte)?
Which analyst is the currently most bullish on HUMA (Humacyte)?
Which analyst is the currently most reserved on HUMA (Humacyte)?
